NYSE:VAPO

Vapotherm - VAPO Stock Forecast, Price & News

$2.03

+0.06 (+3.05%)

(As of 10/5/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.91
▼
$2.12
50-Day Range: $1.44
▼
$2.56
52-Week Range: $1.39
▼
$25.80

Volume: 90,288 shs
Average Volume: 269,506 shs
Market Capitalization: $54.19 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.75

Vapotherm MarketRank™ Forecast

Analyst Rating: Hold
1.80 Rating Score
Upside/Downside: 134.0% Upside
$4.75 Price Target
Short Interest: Healthy
1.59% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$67,000 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($2.87) to ($2.13) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

518th out of 1,072 stocks

Surgical & Medical Instruments Industry

52nd out of 103 stocks

2.9

Analyst's Opinion

Consensus Rating
Vapotherm has received a consensus rating of Hold. The company's average rating score is 1.80, and is based on no buy ratings, 4 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $4.75, Vapotherm has a forecasted upside of 134.0% from its current price of $2.03.
Amount of Analyst Coverage
Vapotherm has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.59% of the float of Vapotherm has been sold short.
Short Interest Ratio / Days to Cover
Vapotherm has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Vapotherm has recently increased by 1.52%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Vapotherm does not currently pay a dividend.
Dividend Growth
Vapotherm does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for VAPO.

1.2

News and Social Media Coverage

News Sentiment
Vapotherm has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Vapotherm this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for VAPO on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Vapotherm insiders have bought more of their company's stock than they have sold. Specifically, they have bought $67,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
10.60% of the stock of Vapotherm is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
54.04% of the stock of Vapotherm is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Vapotherm are expected to grow in the coming year, from ($2.87) to ($2.13) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Vapotherm is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Vapotherm is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Vapotherm has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Vapotherm (NYSE:VAPO) Stock

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

VAPO Stock News Headlines

October 4, 2022 | businesswire.com

Vapotherm Announces Debt Amendment and NYSE Continued Listing Standard Notice - Business Wire

September 28, 2022 | marketwatch.com

Respiratory Devices Market 2022 : Advance Technology, Latest Trend and Future Expansion by 2027

October 6, 2022 | Daily Market Alerts (Ad)

5 Game-Changing Cheap Stocks

These 5 stocks have the potential to outperform the overall market over time because of their future potential. They are well-positioned to deliver a high upside to investors over the next 12 to 18 months. Discover all the details - including name and ticker symbol - here.

September 27, 2022 | markets.businessinsider.com

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday - Markets Insider

September 12, 2022 | globenewswire.com

High Flow Oxygen Therapy Devices Market reach a size of US$ 1.4 Bn by the end of 2032 – GNW - GlobeNewswire

August 12, 2022 | benzinga.com

Vapotherm's Return On Capital Employed Insights - Benzinga

August 10, 2022 | globenewswire.com

Non-invasive Ventilators Market to Exceed a Valuation of US$ 3.9 Bn by 2031, Note Analysts at TMR - GlobeNewswire

August 7, 2022 | seekingalpha.com

Vapotherm, Inc. (VAPO) CEO Joe Army on Q2 2022 Results - Earnings Call Transcript

October 6, 2022 | Vantage Point (Ad)

Trade With Artificial Intelligence for Happiness

There are thousands of trading tools, but only one A.I. that has 2 patents for Predictive Technical Indicators and Intermarket Analysis. People desperately search for more security in their investments, and now is the best time to explore the precision and confidence boosting powers of A.I. Save your seat to register.

August 6, 2022 | in.investing.com

Vapotherm Misses Q2 EPS by 86c By Investing.com - Investing.com India

August 5, 2022 | apnews.com

Vapotherm: Q2 Earnings Snapshot

August 5, 2022 | seekingalpha.com

Vapotherm stock sheds ~31% as Q2 results disappoint, co cuts FY 2022 revenue guidance

August 5, 2022 | markets.businessinsider.com

Where Vapotherm Stands With Analysts

August 4, 2022 | benzinga.com

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022 - Benzinga

August 4, 2022 | seekingalpha.com

Vapotherm stock sheds ~31% as Q2 results disappoint, co cuts FY 2022 revenue guidance - Seeking Alpha

August 4, 2022 | finance.yahoo.com

Vapotherm to Participate in the Canaccord Genuity 42nd Annual Growth Conference

August 4, 2022 | benzinga.com

Gold Tops 1,800; Alibaba Reports Upbeat Results - Benzinga

August 4, 2022 | seekingalpha.com

VAPO stock downgraded at William Blair after 2Q results (NYSE:VAPO) - Seeking Alpha

August 4, 2022 | investing.com

Vapotherm Misses Q2 EPS by 86c By Investing.com - Investing.com

August 4, 2022 | finance.yahoo.com

Vapotherm Reports Second Quarter 2022 Financial Results - Yahoo Finance

August 3, 2022 | ca.investing.com

Vapotherm Misses Q2 EPS by 86c By Investing.com - Investing.com Canada

August 3, 2022 | businesswire.com

Vapotherm Reports Second Quarter 2022 Financial Results - Business Wire

August 3, 2022 | finance.yahoo.com

Vapotherm Reports Second Quarter 2022 Financial Results

August 3, 2022 | finance.yahoo.com

Vapotherm (VAPO) Reports Q2 Loss, Lags Revenue Estimates

July 21, 2022 | finance.yahoo.com

Vapotherm to Report Second Quarter 2022 Financial Results - Yahoo Finance

July 20, 2022 | finance.yahoo.com

Vapotherm to Report Second Quarter 2022 Financial Results

June 24, 2022 | benzinga.com

BTIG Maintains Buy on Vapotherm, Lowers Price Target to $7 - Benzinga - Benzinga

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

VAPO Company Calendar

Last Earnings: 8/03/2022
Today: 10/05/2022
Next Earnings (Estimated): 11/02/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:VAPO
CUSIP: N/A
CIK: 1253176
Web: www.vapotherm.com
Phone: (866) 410-9986
Fax: N/A
Employees: 510
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $4.75
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $2.00
Forecasted Upside/Downside: +134.0%
Consensus Rating: Hold
Rating Score (0-4): 1.80
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.71)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-59,800,000.00
Net Margins: -102.94%
Pretax Margin: -102.94%
Return on Equity: -142.53%
Return on Assets: -47.74%

Debt

Debt-to-Equity Ratio: 7.04
Current Ratio: 5.29
Quick Ratio: 3.25

Sales & Book Value

Annual Sales: $113.29 million
Price / Sales: 0.48
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.56 per share
Price / Book: 0.79

Miscellaneous

Outstanding Shares: 26,697,000
Free Float: 23,867,000
Market Cap: $54.19 million
Optionable: Not Optionable
Beta: -0.02

Key Executives

Mr. Joseph F. Army CPA (Age 58)
CPA, CEO, Pres & Director
Comp: $1.61M

Mr. John Landry (Age 49)
Sr. VP, CFO & Treasurer
Comp: $772.21k

Mr. Gregoire Ramade (Age 52)
Sr. VP & Chief Commercial Officer
Comp: $936.74k

Mr. William Niland
Founder

Ms. Dorota Mckay (Age 40)
Chief Accounting Officer & Controller

Mr. Brian Lawrence (Age 52)
Sr. VP & CTO

Mr. Anthony Ten Haagen
VP of Legal & Compliance

Mr. James A. Lightman (Age 64)
Sr. VP, Gen. Counsel & Sec.

Ms. Lindsay Becker (Age 37)
VP of HR

Dr. Michael C. McQueen FAAP (Age 62)
M.D., MBA, Sr. VP & Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

VAPO Stock - Frequently Asked Questions

Should I buy or sell Vapotherm stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" VAPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VAPO, but not buy additional shares or sell existing shares.
View VAPO analyst ratings or view top-rated stocks.
What is Vapotherm's stock price forecast for 2022?: 5 equities research analysts have issued 12-month price targets for Vapotherm's stock. Their VAPO share price forecasts range from $2.00 to $7.00. On average, they expect the company's stock price to reach $4.75 in the next twelve months. This suggests a possible upside of 134.0% from the stock's current price.
View analysts price targets for VAPO or view top-rated stocks among Wall Street analysts.
How have VAPO shares performed in 2022?: Vapotherm's stock was trading at $20.71 on January 1st, 2022. Since then, VAPO shares have decreased by 90.2% and is now trading at $2.03.
View the best growth stocks for 2022 here.
When is Vapotherm's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our VAPO earnings forecast.
How were Vapotherm's earnings last quarter?: Vapotherm, Inc. (NYSE:VAPO) announced its quarterly earnings data on Wednesday, August, 3rd. The company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.78) by $0.06. The business earned $12.97 million during the quarter, compared to analysts' expectations of $19.34 million. Vapotherm had a negative trailing twelve-month return on equity of 142.53% and a negative net margin of 102.94%.
What guidance has Vapotherm issued on next quarter's earnings?: Vapotherm updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $76.00 million-$81.00 million, compared to the consensus revenue estimate of $81.99 million.

What is Joe Army's approval rating as Vapotherm's CEO?: 65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Vapotherm own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Block (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and
When did Vapotherm IPO?: (VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
What is Vapotherm's stock symbol?: Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."
How do I buy shares of Vapotherm?: Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Vapotherm's stock price today?: One share of VAPO stock can currently be purchased for approximately $2.03.
How much money does Vapotherm make?: Vapotherm (NYSE:VAPO) has a market capitalization of $54.19 million and generates $113.29 million in revenue each year. The company earns $-59,800,000.00 in net income (profit) each year or ($3.71) on an earnings per share basis.
How many employees does Vapotherm have?: The company employs 510 workers across the globe.
How can I contact Vapotherm?: Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The official website for the company is www.vapotherm.com. The company can be reached via phone at (866) 410-9986 or via email at ir@vtherm.com.

This page (NYSE:VAPO) was last updated on 10/6/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vapotherm - VAPO Stock Forecast, Price & News

Vapotherm MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month